Parkinson's Disease Online Powered by the Michael J. Fox Foundation Home
Welcome Guest | Be a part of PD Online Research
  • recover password
FacebookTwitter
  • Discussions
    • LRRK2 Antibodies
    • Protocol Q&A
  • News
    • Papers of the Week
    • Newsletters
  • Resources
    • Genes
    • Research Models
    • Clinical Trials
    • Classifieds
    • PD Guide
  • Funding
    • Funding News
  • Meetings
    • Calendar
    • Meeting Reports
    • Reporter Awards
  • Members
    • Member Directory
    • Apply for Membership

Biblio

  • List
  • Filter
Add Citation
Export 3 results:
  • Endnote
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Ballard, Clive  [Clear All Filters]
2010
Alves G, Brønnick K, Aarsland D, Blennow K, Zetterberg H, Ballard C, et al. CSF amyloid-{beta} and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study. Journal of neurology, neurosurgery, and psychiatry. 2010.
  • Endnote
  • 0
2009
Ballard C, Jones EL, Londos E, Minthon L, Francis P, Aarsland D. alpha-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies. International psychogeriatrics / IPA. 2009:1-7.
  • Endnote
  • 0
Aarsland D, Ballard C, Walker Z, Bostrom F, Alves G, Kossakowski K, et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet neurology. 2009.
  • Endnote
  • 0

Latest Discussions

  • Papers of the Week: Two Weeks of Papers ending September 6, 2010
  • LRRK2 Antibodies
    Responses: 38
  • Members in the News: Charleen T. Chu Receives Outstanding Investigator Award
    Responses: 1
  • Cognitive Problems May Precede PD Motor Symptoms
    Responses: 1
  • Systems Approaches to Parkinson's Disease
    Responses: 15
more

Latest News

  • Parkin Inactivation by Phosphorylation May Explain Some Cases of Sporadic PD
    08 Sep 2010
    In a Nutshell: Parkin, a ubiquitin ligase involved in protein destruction, can be turned off by S-nitrosylation, oxidative stress and dopamine conjugation, and previous research suggests that parkin ... 
  • Michael J. Fox's CNN Opinion Piece: One Step Forward, Two Steps Back
    08 Sep 2010
    Today, CNN.com published an opinion piece by Michael J. Fox regarding the recent injunction halting federal embryonic stem cell funding.  ... 
  • MJFF Statement on Halting of Federal Embryonic Stem Cell Funding
    07 Sep 2010
    MJFF has released an official statement on the recent injunction halting the use of federal funds to support embryonic stem cell research. ... 
  • ReMYND Scores $637M Deal with Roche
    07 Sep 2010
    ReMynd, a Belgian biotech company, announced today that it has received follow-on funding from pharma giant Roche for a potentially disease-modifying Parkinson's drug whose development MJFF ... 
more

Upcoming Events

  • Stem Cells USA and Regenerative Medicine Congress 2010
    13 Sep 2010 - 15 Sep 2010
  • 14th International Biotechnology Symposium
    14 Sep 2010 - 18 Sep 2010
  • Tissue Engineering and Regenerative Medicine International Society 2010 Asia Pacific Meeting
    15 Sep 2010 - 17 Sep 2010
more

Funding Opportunities

  • RFP: Novel Biomarkers to Accelerate Drug Discovery for Frontotemporal Dementias
    The Association for Frontotemporal Dementias
    09 Sep 2010
  • 2011 NIH Director’s Pioneer Award Program (DP1)
    National Institutes of Health (NIH)
    13 Sep 2010
  • Clinical and Basic Research: Parkinson's Disease and Dystonia
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
  • Dekker RFP: Clinical Aspects of Parkinson's Disease
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
  • Dystonia RFP
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
more
  • About
  • Terms
  • who we are
  • The Michael J. Fox Foundation
  • Posting Tips
  • how to cite us
  • contact us
FacebookTwitter